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Objective: Interactions between endothelial cells (ECs) and smooth muscle cells (SMCs) are fundamental in diverse
cardiovascular processes such as arteriogenesis, atherosclerosis, and restenosis. We aimed to determine the intracellular
signaling mechanisms by which ECs promote a differentiated SMC phenotype.
Methods: Bovine thoracic aorta ECs and SMCs were isolated and cultured. For co-culture studies, ECs were grown to
confluence on one side of a semi-permeable Cyclopore membrane. SMCs were then plated on the opposite side of the
membrane and cultured for 24 to 48 hours. For adenovirus experiments, SMCs were infected prior to plating opposite
ECs. For conditioned media studies, SMCs cultured alone on plastic were treated with media harvested from EC/SMC
in co-culture. SMC phenotype was assayed by microscopy and measurement of two-dimensional area, or by western
blotting for contractile protein markers of differentiation. Akt activation was measured by western blotting for
phospho-Serine 473.
Results: Although SMCs cultured alone exhibit a dedifferentiated synthetic phenotype, we report that bilayer co-culture
with ECs induced a differentiated SMC phenotype as measured by morphology and cell area and expression of protein
markers of differentiation, including contractile proteins and the cyclin-dependent kinase inhibitor p27kip. The EC/SMC
bilayer co-culture resulted in activation of the SMC protein kinase Akt, with no effect on total Akt expression. Similarly,
conditioned media from co-cultured EC/SMC promoted rapid Akt phosphorylation and subsequent expression of
differentiation protein markers in SMCs cultured alone. Adenoviral overexpression of constitutively active Akt in SMCs
cultured alone mimicked the ability of ECs to induce SMC differentiation. Notably, inhibition of phosphoinositide 3 (PI
3)-kinase activity with wortmannin or adenoviral overexpression of a dominant-negative Akt prevented the EC-mediated
effect on SMC morphology and differentiation protein marker expression.
Conclusions: ECs direct SMCs towards a differentiated phenotype through activation of the SMC PI 3-kinase/Akt
pathway. (J Vasc Surg 2005;41:509-16.)
Clinical Relevance: Interactions between endothelial cells (ECs) and smooth muscle cells (SMCs) are fundamental in
diverse cardiovascular processes such as arteriogenesis, collateral blood vessel development, atherosclerosis, and resteno-
sis. Alterations in SMC phenotype occur in each of these processes. Endothelial denudation has been suggested to
contribute to the SMC proliferative response to vessel injury by angioplasty or other catheterization procedures. We have
employed a co-culture approach to dissect the molecular signals that are dependent on the spatial relationship between
ECs and SMCs, and have identified the importance of the PI3K/Akt pathway in EC-induced SMC differentiation. This
pathway may suggest targets for therapeutic interventions for intimal hyperplasia and restenosis.Interactions between endothelial cells (ECs) and
smooth muscle cells (SMCs) are fundamental in diverse
cardiovascular processes such as arteriogenesis, collateral
blood vessel development, atherosclerosis, and restenosis.
Alterations in SMC phenotype occur in each of these
processes. After vascular wall injury, SMCs dedifferentiate
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doi:10.1016/j.jvs.2004.12.024from a quiescent contractile phenotype to a synthetic phe-
notype prior to migration, proliferation, andmatrix synthe-
sis, processes that contribute to restenosis.1,2
During arteriogenesis, SMCs dedifferentiate prior to
migration and subsequent formation of new blood vessels
from an existing vessel.3,4 SMCs maintain the capacity to
revert back to a differentiated phenotype so that the newly
formed blood vessel can mature. Thus, SMCs do not
terminally dedifferentiate but retain plasticity to move back
and forth along a continuum between differentiated and
dedifferentiated states. Although there are certainly differ-
ences in the synthetic phenotype of SMCs in the previously
mentioned diverse vascular processes, SMC dedifferentia-
tion from a contractile phenotype is a common theme.
Understanding the factors that promote differentiation is
central to influencing these processes.
SMCs in the adult arterial wall media maintain a differ-
entiated phenotype characterized by a spindle-shaped mor-
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eration, and the ability to contract.5,6 Specific markers of
SMC differentiation include smooth muscle myosin heavy
chain (SM-MHC), smoothelin, calponin, SM -actin, and
1 integrin.
5,7-11 In SMC phenotypic modulation, SMC-
specific contractile proteins are sequentially expressed (or
lost) in a progression that recapitulates that of the original
myoblast-to-myocyte transition.
Hirschi and colleagues12 have shown that ECs can pro-
mote SMC differentiation in a SMC progenitor cell line.
Using an under-agarose gel assay, these investigators have
shown that ECs cultured separately from the SMCprogenitor
cell line 10T1/2 promote migration of this cell line towards
ECs. However, once the ECs and 10T1/2 cells achieve close
contact, ECs promote differentiation of the 10T1/2 cells
to a SMC phenotype.12 Our laboratory and others have
similarly shown that ECs maintain SMCs in a differentiated
phenotype. We have shown that ECs promote SMC differ-
entiation from the synthetic to the contractile phenotype as
measured by cell morphology, differentiation protein marker
expression, and cell contractility.9,13-15
The intracellular signaling mechanisms that regulate
SMC phenotype are not well understood, but the protein
kinase G (PKG),16 peroxisomal proliferator-activated re-
ceptor- (PPAR)17-19 mitogen-activated protein kinase/
extracellular signal-regulated kinase (MAPK/ERK),5 and
phosphoinositide 3 (PI 3)-kinase pathways have been im-
plicated in SMC differentiation. Primary SMCs cultured on
laminin maintain a differentiated phenotype when treated
with insulin-like growth factor (IGF), and this process is
mediated through IGF activation of the PI 3-kinase/Akt
pathway.20 It was subsequently shown that the balance
between the PI 3-kinase/Akt and ERK pathways regulated
the SMC phenotype21 and that calcineurin may be an
important downstream target of Akt in this process.22
The purpose of the present study was to define the
EC-regulated SMC intracellular signaling pathways that
control SMC phenotype expression. The hypothesis tested
was that the SMC phenotype is regulated by EC control of
the SMC PI 3-kinase/Akt pathway. These data provide
important insights into mechanisms of SMC phenotype
regulation that is essential in pathologic and therapeutic
vascular wall remodeling.
METHODS
Cell culture. Bovine thoracic aorta ECs and SMCs
were isolated and cultured in Dulbecco Modified Eagle’s
Medium (DMEM)with 10% calf serum (CS), L-glutamine,
and penicillin-streptomycin, as previously described.13-15
ECs were harvested by scrape technique and SMCs by
explant. ECs were identified by using an antibody to hu-
man von Willebrand factor (Dako-VWF, F8/86, Dako,
Carpinteria, CA). SMCs at passage 2 to 5 were used for
experiments.
Co-culture model. EC (5 105 cells/25 mm2 area
circular well) were plated on the outer side of semi-permeable
Falcon Cell Culture tissue culture inserts (BD Biosciences,
Bedford MA) configured with 0.4-m pores in 6-wellplates (Cyclopore membrane, BD Biosciences) and grown
to confluence over 4 to 5 days. SMCs (1 105) were then
plated on the inner side of the membrane and cultured for
24 hours in DMEM/10% CS. For the control, SMCs were
plated on the inner surface of membranes in the absence of
ECs in DMEM/10% CS.13-15 After 24 hours, both cell
types were placed in DMEM/2.5% CS for the duration of
each experiment. Previous experiments have shown that
2.5% CS promotes submaximal SMC proliferation but does
not itself induce their differentiation.
Conditioned media experiments were conducted by
harvesting the media from both the EC and SMC compart-
ments of the co-culture system after 24 hours, centrifuging
to remove any cells, and adding this media to SMCs cul-
tured alone.
Cell area measurement. SMCs were cultured on cov-
erslips in 6-well plates or on Cyclopore membrane inserts as
described. Cells were fixed with paraformaldehyde, stained
with toluidine blue, and mounted on slides. Ten separate
high-power fields from each slide were photographed, dig-
itized, and the cell area was determined in a blindedmanner
by planimetry. National Institutes of Health (NIH) image
software was used to outline cell dimensions and compute
the two-dimensional area.
Western blot analysis. Lysates were harvested for
Western blot analysis as previously described.23,24 The
Bradford assay was used to determine total protein concen-
tration. Equal amounts of protein per lane were subjected
to sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE), transferred to nitrocellulose membrane,
and immunoblotted using antibodies against SM-MHC
SM2 (Seikagaku America), smoothelin (Abcam) total Akt
or phospho serine 473 Akt (Cell Signaling), phospho serine
9 glycogen synthase kinase 3 (GSK3) (Cell Signaling),
calponin, or SM -actin (Sigma), p27kip (Santa Cruz Bio-
technology), ERK1/2 (gift from John Blenis, Harvard
Medical School) and horseradish peroxidase-conjugated
secondary antibody (Pierce), and detected with chemilumi-
nescence reagents (Amersham, Pierce).
Adenoviral expression of dominant-negative Akt
and myristoylated Akt. Recombinant adenoviruses en-
coding hemagglutinin (HA)-tagged dominant-negative
Akt (dnAkt) or constitutively active myristoylated Akt
(myrAkt) driven by the cytomegalovirus (CMV) promoter
were a gift from Kenneth Walsh.25,26 These viruses co-
express green fluorescent protein (GFP) to easily assess
infection efficiency by fluorescence microscopy. We gener-
ated a control adenovirus expressing GFP alone from the
same CMV promoter.27 Adenoviruses were constructed
using the AdEasy system (see www.coloncancer.org/adeasy
for methods) and amplified in human embryonic kidney
(HEK293E) cells.28 SMCs were infected overnight with
adenoviral supernatant (at 1:20 to 1:50 dilutions) in
DMEM with 10% CS, washed, and replated on co-culture
membranes adjacent to ECs or alone. Optimal titers were
predetermined to yield infection of75% of SMCs. Under
these conditions, ECs were not infected.
alon
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performed in triplicate, and representative blots are shown.
Data were averaged, unless otherwise specified, and pre-
sented as the mean  standard error of the mean (SEM).
Significant differences between groups were tested by the
Student unpaired t test or analysis of variance and post hoc
t test where appropriate. P  .05 was considered signifi-
cant.
Results
ECs induce a differentiated SMC morphology. As
shown in Fig 1, A, ECs induced a more spindle-shaped
appearance in SMCs that is characteristic of the differenti-
ated phenotype when compared with SMC cultured alone.
The induction of a differentiated SMC phenotype by EC
co-culture is also supported by a 75% decrease in cell area of
SMCs cultured opposite ECs compared with SMCs cul-
tured alone (Fig 1, B).
ECs increase SMC phosphorylation of Akt and
increase differentiation protein marker expression in
co-culture. Co-culture with ECs for 48 hours induced
biochemical markers of SMC differentiation. SMC expres-
sion of SM-MHC SM2, the most stringent marker for the
differentiated phenotype,29 increased by 2.2-fold com-
pared with SMCs cultured alone (Fig 2). ECs also increased
expression of the differentiation protein marker smoothelin
by 2.15-fold in co-cultured SMCs compared with SMCs
cultured alone (Fig 2, B). Furthermore, ECs increased by
1.5-fold the expression of the cyclin-dependent kinase in-
hibitor p27kip, known to be associated with a quiescent,
differentiated SMC phenotype (Fig 2, B).30 There was no
Fig 1. Co-culture with endothelial cells induces a differe
crograph (40magnification) comparing cell morpholo
endothelial cells (CC) for 48 hours (see Materials an
planimetry. Results are mean  SEM. *P  .05 vs SMCeffect of ECs on SMC levels of total ERK1/2, which thusserves as a loading control. This process was EC-specific as
co-culture of SMC with NIH 3T3 cells had no effect on
SMCmorphology or differentiation protein marker expres-
sion (data not shown).
As shown in Fig 2, A-C, co-culturing SMCs with ECs
(CC) for 48 hours increased phosphorylation of Akt at serine
473 by 3.2-fold compared with SMCs cultured alone. The
phosphorylation of Akt at serine 473 is known to correlate
with Akt kinase activity. ECs had no effect on the SMC total
Akt expression level. Enhanced SMCAkt activity in co-culture
with ECs is reflected in vivo by an increase in phosphorylation
of the endogenous Akt substrate GSK-3 compared with
SMC cultured alone (Fig 2, A-B). SMC Akt activation was
specifically induced by ECs and was unaffected by SMC co-
culture with NIH 3T3 cells (data not shown).
We have shown previously that conditioned media
from co-cultured SMCs and ECs can promote the differ-
entiated phenotype in recipient SMCs cultured alone.13
Conditioned media was used to address the early kinetics of
Akt activation. The conditioned media system allows the
study of signaling events at earlier time points than conven-
tional co-culture because it eliminates the complex issue of
the time required (at least 30 to 60 minutes) for SMCs to
adhere to and spread on the co-culture insert membrane.
The addition of co-culture–conditioned media to
SMCs cultured alone similarly induced a transient increase
in Akt phosphorylation that peaked after 30 to 60 minutes
and remained elevated above baseline for up to 48 hours
(Fig 3). The increase in Akt phosphorylation (maximal
induction of 48-fold in Fig 3, A, and 10-fold in Fig 3, B)
was associated with a time-dependent increase in the ex-
ed smooth muscle cell (SMC)morphology.A, Photomi-
SMCs cultured alone (SMC) or SMCs co-cultured with
thods). B, Two-dimensional cell area as measured by
e.ntiat
gy of
d Mepression of the differentiation protein markers -actin,
JOURNAL OF VASCULAR SURGERY
March 2005512 Brown et alcalponin, and SM2-MHC, with maximal expression (3.3-
fold, 3.9-fold, and 3.5-fold inductions, respectively) at
48 hours after exposure to conditioned media from co-
cultured cells (Fig 3).
Constitutive Akt activity promotes a differentiated
SMCphenotype. SMCs cultured alone were infected with
an adenovirus expressing a constitutively active HA
epitope-tagged myristoylated Akt (HA-myrAkt). As shown
in Fig 4, SMCs cultured alone expressing HA-myrAkt had
increased expression of smooth muscle SM-MHC SM2
compared with uninfected and cells infected with the neg-
ative control adenovirus. The enhanced in vivo Akt activity
in the SMCs expressing the HA-myrAkt construct is indi-
cated by the increase in phosphorylation of the endogenous
Akt substrate GSK-3.
Inhibition of PI 3-kinase inhibits EC-induced SMC
differentiation. Inhibition of the PI 3-kinase pathway
with 100 nMwortmannin prevented the EC effect on SMC
morphology (Fig 5, A). SMC co-cultured with ECs exhib-
ited a spindle-shaped morphology indicative of the differ-
Fig 2. Co-culture induces biochemical markers of smoo
A, SMCs were cultured alone or co-cultured opposite end
blotting with antibodies recognizing smooth muscle
(P-Ser473) Akt, total Akt, and phospho-serine 9 glycog
above in A and SMCs analyzed by Western blotting with
P-Ser9 GSK-3, p27kip, and total extracellular signal-reg
densitometry data for SM2 (*P 0.05), P-Ser473 Akt (
Results are mean  SEM.entiated phenotype. In contrast, treatment of SMC in ECco-culture with the PI 3-kinase inhibitor wortmannin re-
sulted in a hypertrophic appearance similar to that of SMC
cultured alone. This morphologic difference was quanti-
tated by planimetry as in Fig 1. Co-cultured SMCs treated
with wortmannin had a 2.1-fold increase in cell area com-
pared with SMCs co-cultured with ECs in the absence of
wortmannin. Wortmannin-treated SMCs in co-culture
were similar in size to synthetic phenotype SMCs cultured
alone (Fig 5, A). The structurally distinct PI 3-kinase
inhibitor LY294002 also prevented the EC-mediated ef-
fects on SMC morphology and cell size (data not shown).
As shown in Fig 5, B, inhibition of the PI 3-kinase
pathway with the specific inhibitor wortmannin blocked
the EC-mediated activation of SMC Akt as measured by
Akt serine 473 phosphorylation, as expected. Notably,
inhibition of the PI 3-kinase pathway also prevented the
EC-mediated increase in expression of the differentiation
protein marker SM2-MHC.
Specific inhibition of Akt with a dominant negative
Akt adenovirus inhibits EC effect on SMC phenotype.
uscle cell (SMC) differentiation and activates SMC Akt.
ial cells (CC) for 48 hours and were analyzed byWestern
yosin heavy chain (SM2-MHC), phospho-serine 473
thase kinase 3 (P-GSK-3). B, Cells were cultured as
odies recognizing smoothelin, P-Ser473 Akt, total Akt,
kinase (ERK1/2) (loading control).C,Corresponding
 .008), and total Akt from three replicate experiments.th m
othel
2-m
en syn
antib
ulated
** PAs shown in Fig 6, Akt inhibition prevented EC promotion
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with a dnAkt-expressing adenovirus prior to co-culture had
a similar morphology to SMCs cultured alone that were
infected with a negative control adenovirus or uninfected.
Fig 3. Co-culture–conditioned media induces smooth
Conditioned media from SMC and endothelial cell 24-h
SMCs were analyzed at the subsequent time points indica
473) B, SMCs were treated with conditioned media as i
Western blotting for the indicated antibodies (ERK1
SM2-MHC, smooth muscle 2-myosin heavy chain).
Fig 4. Overexpression of constitutively active Akt induces
smooth muscle cell (SMC) differentiation. SMC were cultured
alone and infected with adenovirus encoding green fluorescent
protein (GFP) only (Ctrl), constitutively active hemagglutinin
(HA)-tagged myristoylated Akt (MyrAkt), or were uninfected
(Uninf) overnight. Cells were washed, re-fed, and assayed by
Western blotting 24 hours later with antibodies recognizing
smooth muscle 2-myosin heavy chain (SM2-MHC), the HA-
epitope tag (HA-myrAkt), phospho-serine 9 glycogen synthase
kinase 3 (GSK-3), and total extracellular signal-regulated kinase
(ERK1/2) (loading control).The effects on SMC morphology are quantitatively re-flected in the cell area measurement (Fig. 6). In uninfected
or control-infected SMC, co-culture with EC reduced
SMC area by 63% to 46%, respectively. In contrast, dnAkt
overexpression inhibited the co-culture effect on cell area.
The size of dnAkt-infected SMC in co-culture or cultured
alone was similar to that of control or uninfected SMC
cultured alone (synthetic phenotype).
DISCUSSION
We have previously demonstrated that EC co-culture
promotes phenotypic modulation of dedifferentiated
SMCs.9,13-15 Here, we report that EC co-culture promotes
this differentiated phenotype through activation of the
SMC PI 3-K/Akt pathway. Co-culture induces a rapid,
sustained activation of Akt in the SMC, and inhibition of
Akt signaling with pharmacologic inhibitors or dnAkt pre-
vents the EC-induced SMC changes in morphology and
contractile protein expression. Notably, this work is the first
demonstration that constitutively active Akt is sufficient to
promote re-differentiation of synthetic phenotype SMCs
cultured alone.
The role of the IGF/PI 3-K/Akt pathway in skeletal
muscle differentiation is documented in numerous re-
ports.31-34 This pathway regulates expression or activity
(or both), of skeletal muscle-specific differentiation-pro-
moting transcription factors, including myocyte en-
hancer factor-2 (MEF2) and MyoD,35 and these tran-
scription factors in turn provide autocrine feedback
regulation of IGF and its receptor.34 Smooth muscle
le cell (SMC) differentiation and activates SMC Akt. A,
co-culture was added at time 0 to SMC cultured alone.
Western blotting as in Fig 2. (P-Ser473, phospho-serine
nd analyzed at the subsequent time points indicated by
extracellular signal-regulated kinase] loading control)musc
our
ted by
n A a
/2 [homologs of these transcription factors have yet to be
(SM
vs all
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factors may play analogous roles. The terminal differen-
tiation of skeletal muscle suggests there may be signifi-
cant differences in skeletal muscle versus reversible
smooth muscle differentiation, but given the conserva-
tion of the IGF/PI 3-K/Akt pathway, this system may
reveal future mechanistic similarities as well.
The best evidence for a role of the IGF/PI 3-K/Akt
pathway comes from the work of Hayashi and col-
leagues.20,21 Although most growth factors promote SMC
Fig 5. Wortmannin prevents co-culture–induced differe
co-cultured opposite endothelial cells for 48 hours, and t
SMCs for the 48-hour duration.A, SMC area as determin
black striped bar, SMC in co-culture with vehicle (P  0
wortmannin; gray striped bar, SMC in co-culture with w
above in A and analyzed by Western blotting as in Fig 2
Fig 6. Dominant-negative Akt (dnAkt) inhibits co-cu
were infected with dnAkt or control (green fluorescent p
trypsinized, and replated opposite confluent endothelial
area as measured by planimetry is shown. Solid bars, SM
SEM. *P  .05 for uninfected-CC or control virus-CCproliferation or migration, or both, they found that IGFprevented the dedifferentiation of primary (contractile)
SMCs cultured on laminin and that this process was medi-
ated by IGF activation of the PI 3-kinase/Akt path-
way.20,21 Subsequent work has shown that calcineurin, a
downstream target of Akt, contributes to a differentiated
phenotype in visceral SMC.22 It is likely that additional as
yet unidentified laminin-regulated pathways are also in-
volved. Interestingly, PI 3-kinase/Akt signaling increased
laminin transcription, synthesis, and translocation to the
basement membrane in differentiating C2 skeletal myo-
ion. Smooth muscle cells (SMCs) were cultured alone or
00 nM wortmannin or vehicle control was added to the
planimetry. Black bar, SMC cultured alone with vehicle;
lative to all others); gray bar, SMC cultured alone with
annin. Data are mean  SEM. B, SMC were treated as
2-MHC, smooth muscle 2-myosin heavy chain).
induced differentiation. Smooth muscle cells (SMCs)
[GFP]) adenoviruses, or uninfected overnight, washed,
in co-culture (CC) for 48 hours. Two-dimensional cell
ne; stippled bars, SMC in co-culture. Data are mean 
other groups.ntiat
hen 1
ed by
.05 re
ortmlture–
rotein
cells
C aloblasts.36
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SMC PI 3-kinase/Akt is presently unknown. We have
shown that conditioned media from co-cultured EC/SMC
can promote SMC differentiation, but that the kinetics of
the differentiation response are delayed relative to co-
culture.37 However, conditioned media from either ECs or
SMCs cultured alone does not induce differentiation. In
fact, conditioned media from ECs cultured alone induces
SMC proliferation, migration, and protein synthesis.38
Therefore, we hypothesize that the co-culture of ECs and
SMCs promotes release of an EC-derived soluble mediator
that acts on SMCs.
The early peak followed by slow decay of Akt phos-
phorylation in our conditioned media experiments is likely
due to depletion of this soluble mediator(s), as the condi-
tioned media was not replenished over the 48-hour course
of the experiment. Based on the work of Hayashi et al20,21
and on parallels in skeletal muscle, the IGFs attractive
candidates for such a mediator. We are investigating IGF-I
and other factors such as EC-secreted matrix proteins as
potential mediators of the co-culture–induced SMC differ-
entiation.
We are currently exploring roles for downstream tar-
gets of Akt in co-culture–induced SMC differentiation.
Such targets are likely to include calcineurin, as a recent
study showed that constitutively active calcineurin could
rescue dedifferentiation–induced by inhibition of Akt in
visceral SMCs.22 Another indirect target of Akt signaling in
SMC differentiation may be PPAR. PPAR ligands pro-
mote expression of SMC differentiation markers19 and
inhibit intimal hyperplasia,17 and PDGF has been shown to
induce PPAR expression through an Akt-dependent
mechanism.39
Another important function of Akt activation may be
direct inhibition of Raf, and subsequent ERK inhibition.40
Reusch et al40 demonstrated that the relative signal
strength and duration of PI 3-K/Akt versus ERK activation
determines whether an agonist promotes or inhibits SMC
differentiation. The importance of the relationship between
PI 3-K/Akt and ERK signaling is underscored by the work
of Hayashi et al,21 who propose that strong PI 3-K/Akt
signals promote SMC differentiation, whereas strong ERK
signals inhibit.21
Our co-culture model has shown that the SMCs send
projections through the membrane pores that can make
direct contact with the ECs after 4 days.13 However, we
have observed the SMC differentiation response after less
than 1 day in co-culture. That conditioned media recapit-
ulates the phenotype suggests cell–cell contact is not re-
quired for the SMC phenotypic modulation or Akt activa-
tion. However, we cannot rule out a possible contribution
of EC-derived extracellular matrix components as modula-
tors of the SMC differentiation.
We hypothesize that EC/SMC co-culture partially re-
capitulates the signals that arise from the relationship be-
tween these cell types in an intact vessel. Endothelial denu-
dation has been suggested to contribute to the proliferative
response of SMC to vessel injury by angioplasty or othercatheterization procedures.41-43 As such, seeding grafts
with ECs has been a therapeutic strategy for the prevention
of intimal hyperplasia in graft segments.44
Dissecting the signals that are dependent on the spatial
relationship between these cell types may suggest other
targets for modulation of intimal hyperplasia, restenosis,
and angiogenesis. A recent in vitro study revealed distinct
differences in proliferative responses of SMCs in cell culture
versus in intact organ culture after serum stimulation.
SMCs entered S phase in cell culture but not in organ
culture.30 This difference was attributed to the activity of
cyclin-dependent kinase inhibitors in the SMC in the organ
culture, but not in the cell culture. In cell culture, p27kip
and other cyclin-dependent kinase inhibitors were down-
regulated by serum but persisted in the organ culture.
Notably, we observe that p27kip is induced by EC co-
culture. Thus, expression of SMC p27kip in EC/SMC
co-culture resembles the phenotype of the intact tissue.
We have shown that EC co-culture-induced differenti-
ation of SMC is mediated by the PI 3-K/Akt pathway.
Further elucidation of the factors upstream and down-
stream will add to our understanding of the SMC pheno-
typic modulation critical to many normal and pathologic
processes in vascular biology.
We thank Dr Kenneth Walsh for kindly providing the
Akt adenoviruses and Dr John Blenis for the gift of anti-
ERK1/2 antibody.
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